{{Rsnum
|rsid=137852676
|Chromosome=11
|Orientation=minus
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=ABCC8
|position=17395852
|Gene_s=ABCC8
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
}}{{omim
|id=600509
|variant=0025
|rsnum=137852676
}}{{ClinVar
|rsid=137852676
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=17417399
|CHROM=11
|dbSNPBuildID=133
|SSR=0
|SAO=1
|VP=0x050268000000000002110100
|GENEINFO=ABCC8:6833
|GENE_NAME=ABCC8
|GENE_ID=6833
|WGT=0
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000011.9:g.17417399C>T
|CLNSRC=OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=600509.0025
|CLNSIG=4
|CLNCUI=C1833104
|CLNDBN=familial hyperinsulinism
|Disease=familial hyperinsulinism
|CLNACC=RCV000029263.1
|Tags=RV;PM;PMC;S3D;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:MedGen
|CLNDSDBID=NBK1375:CN043604
}}{{PMID|16357}} [Pharmacokinetics of glaphenine in subjects with normal renal function and in patients with chronic renal insufficiency].

{{PMID|14715863}} Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation.

{{PMID|17378627}} Genotype-phenotype associations in patients with severe hyperinsulinism of infancy.

{{PMID|17668386|OA=1
}} Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.

{{PMID|18025408}} Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.

{{PMID|18436707|OA=1
}} Neonatal diabetes mellitus.